ADARx Pharmaceuticals

2 articles

ADARx Pharmaceuticals raises $446.3 million in upsized US IPO

ADARx Pharmaceuticals secured $446.3 million in an upsized US IPO, with AbbVie investing up to $100 million in a concurrent private placement. The San Diego-based developer plans to advance its lead c

reuters · 2026-09-25 04:04

ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO

ADARx Pharmaceuticals seeks a $1.74 billion valuation in its U.S. IPO, aiming to raise $371.9 million while AbbVie secures a 4.9% stake through a concurrent private placement ahead of its Nasdaq listi

reuters · 2026-09-21 03:34